Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 3948242)

Published in Proc Natl Acad Sci U S A on February 18, 2014

Authors

Matthew Owens1, Joe Herbert, Peter B Jones, Barbara J Sahakian, Paul O Wilkinson, Valerie J Dunn, Timothy J Croudace, Ian M Goodyer

Author Affiliations

1: Developmental and Lifecourse Research Group, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, United Kingdom.

Articles citing this

The ROOTS study: a 10-year review of findings on adolescent depression, and recommendations for future longitudinal research. Soc Psychiatry Psychiatr Epidemiol (2015) 1.42

HPA-axis reactivity interacts with stage of pubertal development to predict the onset of depression. Psychoneuroendocrinology (2015) 0.85

Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies. Dialogues Clin Neurosci (2014) 0.84

Developmental mediation of genetic variation in response to the Fast Track prevention program. Dev Psychopathol (2015) 0.79

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder. Front Psychiatry (2016) 0.79

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA). PLoS One (2016) 0.78

Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior. Neuropsychopharmacology (2015) 0.78

Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control. Brain Behav Immun (2014) 0.78

Identification of resilient individuals and those at risk for performance deficits under stress. Front Neurosci (2015) 0.77

Predicting first onset of depression in young girls: Interaction of diurnal cortisol and negative life events. J Abnorm Psychol (2015) 0.77

Maternal postnatal depression predicts altered offspring biological stress reactivity in adulthood. Psychoneuroendocrinology (2014) 0.76

Adolescent over-general memory, life events and mental health outcomes: Findings from a UK cohort study. Memory (2015) 0.76

Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice. J Neuroinflammation (2015) 0.75

Age of Trauma Onset and HPA Axis Dysregulation Among Trauma-Exposed Youth. J Trauma Stress (2015) 0.75

Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: a preliminary analysis. Transl Psychiatry (2017) 0.75

Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics. Transl Psychiatry (2016) 0.75

Characterising the latent structure and organisation of self-reported thoughts, feelings and behaviours in adolescents and young adults. PLoS One (2017) 0.75

Corticosterone exposure augments sensitivity to the behavioral and neuroplastic effects of fluoxetine in C57BL/6 mice. Neurobiol Stress (2016) 0.75

Parental support buffers the association of depressive symptoms with cortisol and C-reactive protein during adolescence. Brain Behav Immun (2016) 0.75

Reduction in adolescent depression after contact with mental health services: a longitudinal cohort study in the UK. Lancet Psychiatry (2017) 0.75

HPA-axis stress reactivity in youth depression: evidence of impaired regulatory processes in depressed boys. Stress (2015) 0.75

Diurnal Cortisol Interacts With Stressful Events to Prospectively Predict Depressive Symptoms in Adolescent Girls. J Adolesc Health (2017) 0.75

Articles cited by this

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry (2010) 16.89

Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol (1998) 8.87

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology (2000) 5.14

The diagnosis of mental disorders: the problem of reification. Annu Rev Clin Psychol (2010) 4.70

Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev Psychopathol (2001) 4.55

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry (2007) 3.78

Sex differences in HPA axis responses to stress: a review. Biol Psychol (2004) 3.75

Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med (1998) 3.67

Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry (1988) 3.43

The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry (2008) 3.40

Autobiographical memory specificity and emotional disorder. Psychol Bull (2007) 3.37

Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? Am J Psychiatry (1999) 2.45

Autobiographical memory in suicide attempters. J Abnorm Psychol (1986) 2.41

Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry (2010) 2.32

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med (2011) 2.30

Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry (2006) 2.28

Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: pragmatic cluster randomised controlled trial. BMJ (2012) 2.05

Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ (2013) 1.71

Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc Natl Acad Sci U S A (2012) 1.67

Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence. Nat Neurosci (2012) 1.66

Influence of early life stress on later hypothalamic-pituitary-adrenal axis functioning and its covariation with mental health symptoms: a study of the allostatic process from childhood into adolescence. Dev Psychopathol (2011) 1.54

Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence. Dev Psychobiol (2011) 1.38

Key Characteristics of Major Depressive Disorder Occurring in Childhood, Adolescence, Emerging Adulthood, Adulthood. Clin Psychol Sci (2013) 1.24

Prodromal symptoms and atypical affectivity as predictors of major depression in juveniles: implications for prevention. J Child Psychol Psychiatry (2010) 1.22

First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset. Br J Psychiatry (2000) 1.21

Effects of induced rumination and distraction on mood and overgeneral autobiographical memory in adolescent Major Depressive Disorder and controls. J Child Psychol Psychiatry (2004) 1.18

Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. Br J Psychiatry (2009) 1.18

Adult mental health disorders and their age at onset. Br J Psychiatry Suppl (2013) 1.18

Categoric overgeneral autobiographical memory in adolescents with major depressive disorder. Psychol Med (2002) 1.17

Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health. BMC Psychiatry (2011) 1.15

Selected executive skills in adolescents with recent first episode major depression. J Child Psychol Psychiatry (2005) 1.15

In search of HPA axis dysregulation in child and adolescent depression. Clin Child Fam Psychol Rev (2011) 1.11

Research review: evaluating and reformulating the developmental taxonomic theory of antisocial behaviour. J Child Psychol Psychiatry (2013) 1.09

Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev (2013) 1.08

Cortisol and depression: three questions for psychiatry. Psychol Med (2012) 1.03

Drug research: a plan for mental illness. Nature (2012) 1.03

Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biol Mood Anxiety Disord (2013) 1.02

Structure and measurement of depression in youths: applying item response theory to clinical data. Psychol Assess (2011) 0.97

A UK strategy for mental health and wellbeing. Lancet (2010) 0.95

Treated depression in adolescents: predictors of outcome at 28 weeks. Br J Psychiatry (2009) 0.88

Emanuel Miller Lecture: early onset depressions--meanings, mechanisms and processes. J Child Psychol Psychiatry (2008) 0.87

5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence. PLoS One (2012) 0.85

Sex differences in the ovine fetal cortisol response to stress. Pediatr Res (2011) 0.85

Specificity of autobiographical memories and basal cortisol levels in patients with major depression. Psychoneuroendocrinology (2005) 0.81

Effects of acute cortisol administration on autobiographical memory in patients with major depression and healthy controls. Psychoneuroendocrinology (2009) 0.81

Dose-dependent effects of hydrocortisone infusion on autobiographical memory recall. Behav Neurosci (2011) 0.80

The challenge of mapping diagnostic categories onto developmental pathophysiology: DSM-6 anyone? J Child Psychol Psychiatry (2013) 0.79

Articles by these authors

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27

Grand challenges in global mental health. Nature (2011) 8.40

Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84

Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03

Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99

Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80

The mental wealth of nations. Nature (2008) 3.60

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev (2007) 3.51

Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35

Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71

Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70

Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55

Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41

Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41

The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry (2002) 2.35

Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33

Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry (2006) 2.28

Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24

Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20

Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17

Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17

Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc (2004) 2.12

A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11

Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11

Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09

A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09

Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06

Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99

Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96

Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94

Brain structure abnormalities in early-onset and adolescent-onset conduct disorder. Am J Psychiatry (2011) 1.94

Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci (2009) 1.92

Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92

The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89

The Short Mood and Feelings Questionnaire (SMFQ): a unidimensional item response theory and categorical data factor analysis of self-report ratings from a community sample of 7-through 11-year-old children. J Abnorm Child Psychol (2006) 1.85

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82

Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81

Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81

Lifting the veil on trichotillomania. Am J Psychiatry (2007) 1.81

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.80

Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79

Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl) (2009) 1.76

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76

Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biol Psychiatry (2004) 1.73

Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72

Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71

Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) (2008) 1.71

Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 1.71

Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69

Neuropsychologic function three to six months following admission to the PICU with meningoencephalitis, sepsis, and other disorders: a prospective study of school-aged children. Crit Care Med (2013) 1.67

Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65

The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62

White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry (2008) 1.60

Disturbances in morning cortisol secretion in association with maternal postnatal depression predict subsequent depressive symptomatology in adolescents. Biol Psychiatry (2006) 1.60

Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.56

Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiatry (2004) 1.56

Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry (2012) 1.55

Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54

Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54

Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54

Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53

Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry (2004) 1.50

The effects of tryptophan depletion on neural responses to emotional words in remitted depression. Biol Psychiatry (2009) 1.50

Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology (2005) 1.49

The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia (2003) 1.48

Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Am J Psychiatry (2005) 1.48

A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47

Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46

Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry (2010) 1.45

Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 1.43

Cognitive mechanisms of treatment in depression. Neuropsychopharmacology (2011) 1.43

Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42

Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42

Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42

Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction (2009) 1.41

Neural abnormalities in early-onset and adolescence-onset conduct disorder. Arch Gen Psychiatry (2010) 1.40

Salivary cortisol and dehydroepiandrosterone in relation to puberty and gender. Psychoneuroendocrinology (2004) 1.40

Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 1.38

Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37

Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage (2008) 1.37

Reward/Punishment reversal learning in older suicide attempters. Am J Psychiatry (2010) 1.36

The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35

CMIP and ATP2C2 modulate phonological short-term memory in language impairment. Am J Hum Genet (2009) 1.34

Deficits in facial expression recognition in male adolescents with early-onset or adolescence-onset conduct disorder. J Child Psychol Psychiatry (2009) 1.33

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32

Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31

Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychol Med (2005) 1.31

Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30